A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and conferred improved outcomes and insulin independence at 1 year in a small study of ...

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically significant ...

Genentech, part of the Roche Group (OTCQX:RHHBY), said that a late-stage study testing Lunsumio, along with Polivy, showed ...

Trump’s One Big Beautiful Bill threatens rural hospitals. Fox News personalities have falsely claimed immigrants are ...

A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...

In CAR T-cell therapy for diffuse large B-cell lymphoma, distinct archetypes could guide personalized treatment decisions.

Discover how South Africa is leading the way in pharmaceutical research and development, ensuring affordable and effective ...

Mitapivat, the first-in-class allosteric activator of pyruvate kinase, is specifically designed to target pyruvate kinase R in red blood cells ... With its favourable adverse event profile, mitapivat ...

A new obesity drug combining four hormones may outperform Wegovy and Mounjaro. Learn what it means for health, science, and investors.

TRAINING IN ENDOVASCULAR SURGERY DURING THE MECHANICAL THROMBECTOMY (MT) INNOVATION BOOM. I was fortunate to have completed ...

BPM31510 provides encouraging evidence of the potential for transformative benefit for a disease with high unmet need, supporting further development. The Company plans to seek guidance in Q3 2025 ...